Minimally Invasive Spine Access Patents: Leaders & White Space 2026
Minimally Invasive Spine Access Patents: Who Leads and Where the Claims Sit
Filings are concentrated but not locked up. the leading assignee holds 292 records while the top 5 combined account for only 18.2% of all 5,079 records in scope — a long tail of single- and few-filing entrants remains active. Volume climbed from 164 records in 2017 toward a peak of 289 in 2020, then eased to 262 in 2021 and 138 by 2024 — a -47% move over that three-year span. Because publication trails filing by roughly 18 months, 2025 and 2026 figures are still incomplete and are not evidence of a genuine falloff yet.
- 1AURIS HEALTH INC5.7%
- 2BOSTON SCIENTIFIC SCIMED INC5.6%
- 3ST JUDE MEDICAL CARDILOGY DIV INC2.5%
- 4WARSAW ORTHOPEDIC INC2.3%
- 5GLOBUS MEDICAL INC2.1%
See the full minimally invasive spine access analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in minimally invasive spine access?
One assignee leads clearly with 292 records, well ahead of the fifth-ranked company at 107 and the tenth at 72. However, the top 5 assignees combined account for only 18.2% of the 5,079 records in scope, so leadership here is not the same as market lock-up. A large share of filings sit with companies further down a ranked list of 100 assignees, meaning freedom-to-operate work has to look beyond the obvious names.
Is patent filing in this space still growing?
Filing volume peaked in 2020 at 289 records and has declined since, with 2021’s 262 records falling to 138 by 2024, a -47% move. That is a real slowdown across a complete three-year window, not a lag artefact. Figures for 2025 and 2026 are still incomplete because publication trails filing by roughly 18 months, so those most recent years should not yet be read as confirming a continued decline.
What technology areas dominate minimally invasive spine access filings?
Diagnosis and surgery classification (A61B) covers 75.4% of the 5,079 records, making it by far the dominant category. Devices for handling body fluids (A61M) and implants (A61F) follow at 30.3% and 25.4% respectively. Image data processing (G06T) and electrotherapy (A61N) are present but much thinner, at 1.4% and 4.9%, which points to comparatively open claim space in the navigation and energy-delivery layers around access hardware.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Minimally Invasive Spine Access covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.